Trial of CPX-351 in Newly Diagnosed Elderly AML Patients
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00788892. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase IIB, Multicenter, Randomized, Open Label Trial of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection Versus Cytarabine and Daunorubicin in Patients With Untreated AML 60-75 Years of Age.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study investigates if CPX-351 will be a) more effective than the standard AML treatment and b) more tolerable than the standard AML treatment regimens. The study compares the investigational product CPX-351 vs the standard treatment for AML in this patients age group.
Study identification
- NCT ID
- NCT00788892
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 126 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 60 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2008 (Type not available)
- Primary completion
- Jun 2010 (Actual)
- Completion
- Dec 2011 (Actual)
- Last update posted
- Jan 12, 2018
2008 – 2011
United States locations
- U.S. sites
- 25
- U.S. states
- 16
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Cancer Center | Tucson | Arizona | 85724-5024 | — |
| Cedars Sinai Medical Center | Los Angeles | California | 90048 | — |
| UC Davis Cancer Center | Sacramento | California | 95817 | — |
| University of California Medical Center | San Francisco | California | 94143 | — |
| University of Colorado Cancer Center | Aurora | Colorado | 80045 | — |
| Shands Jacksonville Medical Center | Jacksonville | Florida | 32209 | — |
| H Lee Moffitt Cancer Center and Research Institute | Tampa | Florida | 33612 | — |
| Blood and Marrow Transplant Group of Georgia | Atlanta | Georgia | 30342 | — |
| Robert H.Lurie Comprehensive Cancer Center | Chicago | Illinois | 60611 | — |
| Rush University Medical Center | Chicago | Illinois | 60612-3861 | — |
| St.Francis Hospital | Beech Grove | Indiana | 46107 | — |
| Dartmouth-Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | — |
| Northern New Jersey Cancer Associates | Hackensack | New Jersey | 07601 | — |
| North Shore University Hospital | Manhasset | New York | 11020 | — |
| Weil Cornell Medical Center | New York | New York | 10021 | — |
| New York Medical College, Division of Oncology | Valhalla | New York | 10595 | — |
| Blumenthal Cancer Center/Mecklenburg Medical Group | Charlotte | North Carolina | 28204 | — |
| Jewish Hospital | Cincinnati | Ohio | 45236 | — |
| Oregon Health and Science University | Portland | Oregon | 97239 | — |
| University of Pittsburg Cancer Center | Pittsburgh | Pennsylvania | 15232 | — |
| MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| Joe Arrington Cancer Center | Lubbock | Texas | 79410 | — |
| Texas Tech University Health Sciences Center | Lubbock | Texas | 79415 | — |
| Cancer Therapy and Research Center at the University of Texas | San Antonio | Texas | 78229 | — |
| Froedlert Hospital/Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00788892, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 12, 2018 · Synced Nov 15, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.